EDEM2 Antikörper (AA 22-300) (HRP)
Kurzübersicht für EDEM2 Antikörper (AA 22-300) (HRP) (ABIN7151977)
Target
Alle EDEM2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 22-300
- 
                                            Kreuzreaktivität
- Human
- 
                                            Aufreinigung
- >95%, Protein G purified
- 
                                            Immunogen
- Recombinant Human ER degradation-enhancing alpha-mannosidase-like protein 2 protein (22-300AA)
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C,-80 °C
- 
                                            Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - EDEM2 (ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2))
- 
                                            Andere Bezeichnung
- EDEM2
- 
                                            Hintergrund
- 
                        Background: Initiates the endoplasmic reticulum-associated degradation (ERAD) that targets misfolded glycoproteins for degradation in an N-glycan-dependent manner. Catalyzes the first mannose trimming step, from Man9GlcNAc2 to Man8GlcNAc2 (PubMed:25092655). Extracts misfolded glycoproteins, but not glycoproteins undergoing productive folding, from the calnexin cycle. Aliases: bA4204.1 antibody, C20orf31 antibody, C20orf49 antibody, EDEM 2 antibody, EDEM2 antibody, EDEM2_HUMAN antibody, ER degradation enhancer mannosidase alpha like 2 antibody, ER degradation enhancing alpha mannosidase like 2 antibody, ER degradation enhancing alpha mannosidase like protein 2 antibody, ER degradation enhancing mannosidase like protein 2 antibody, ER degradation-enhancing alpha-mannosidase-like 2 antibody, FLJ10783 antibody, UNQ573/PRO1135 antibody 
- 
                                            UniProt
- Q9BV94
 Target
- 
                    
 
                                     
                                     
                                    